H. Silverman

Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations.

Develops pharmaceuticals for dermatologic conditions

Functions as a College/University

Functions as a College/University

Offers residential and office furnishings

Provides management consulting services

Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements.

Agman Capital invests in both private and public companies located in the United States. The firm focuses on companies operating in the fields of hospitality and insurance. It provides financing in the form of debt and equity for real estate, buyout and early stage transactions. The firm acquires controlling and minority interest.

Engages in conceptualizing, constructing and managing hotels